Peer-influenced content. Sources you trust. No registration required. This is HCN.

Multiple Sclerosis News TodayAI Model is Able to Predict MS Risk Years Before Disease Onset

Breakthrough Algorithm Identifies Potential Multiple Sclerosis Patients Prior to Symptom Emergence

A groundbreaking artificial intelligence algorithm has been developed that can identify individuals at risk of developing multiple sclerosis (MS) years before any neurological symptoms manifest. Presented at the 2023 American Association for Clinical Chemistry Annual Scientific Meeting, this innovative approach could revolutionize early detection and treatment planning for MS.

Key Points:

  • The AI model, known as a random forest model, was created using data from more than 3,000 people.
  • Information in the model included age, gender, metabolic data, and specific blood markers.
  • The model demonstrated strong predictive power and high accuracy.
  • Potential applications include periodic monitoring for neurological and cognitive exams, and guiding treatment decisions.

Additional Points:

  • Another study at the meeting presented a machine learning algorithm to detect contamination in blood samples.
  • This new method detected up to 10 times more types of contaminating chemicals than current methods.
  • It accurately identified sources of contamination that have been difficult to catch with existing techniques.


  • These advancements in AI and machine learning not only offer promising avenues for early MS risk prediction but also enhance the quality and accuracy of blood sample analysis.

Related Posts

“While this won’t immediately reduce the number of contaminated tests, it will hopefully substantially reduce the operational and clinical impact of these events when they do happen and provide us with a better quality metric with which we can prioritize areas for improvement initiatives.”

Nicholas Spies, MD
Lead Researcher on the Project
Washington University School of Medicine
St. Louis, MO
The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form